International Union Against Cancer

IUAC / International Union Against Cancer
RGP / Research Grants and Projects Office

WEBSITE: Access the UICC Website

SCIENTIFIC AREAS: The UICC Fellowships Program provides long, medium and short-term fellowships abroad to qualified investigators, clinicians, and nurses, who are actively engaged in cancer research, clinical oncology, oncology nursing or are educators in these fields.
Types of Fellowships:

  1. Beginning Investigators: American Cancer Society international fellowships for beginning investigators (ACSBI) emphasizes the transfer of knowledge from the host institute to others at the home institute.
  2. Study Grants: Yamagiwa-Yoshida Memorial international study grants provide an important opportunity to advance cancer research through international collaboration.
  3. Technology Transfer: International cancer technology transfer fellowships (ICRETT) aim to facilitate rapid international transfer of cancer research and clinical technology.
  4. Training Workshops: Bring an expert panel to your institution to teach a workshop.

AMOUNT:

  1. Beginning Investigators: $50,000
  2. Study Grants: $10,000
  3. Technology Transfer and Cervical Cancer Initiative (CCI) Fellowships: the average value is $3400.
  4. Training Workshops: Up to $15,000 for travel and stipend for 3 international faculty members

SUPPORT PERIOD:

  1. Beginning investigators: 1 year.
  2. Study Grants: 3 months.
  3. Technology Transfer and Cervical Cancer Initiative (CCI) Fellowships: 1 month.
  4. Training Workshops: 3-5 days.

SUBMISSION DATE(S):

  1. Beginning investigators: 1 November 2011.
  2. Study Grants:
    • 15 January 2012
    • 1 July 2012
  3. Technology Transfer: year-round.
  4. Training Workshops: year-round.

MODE OF APPLICATION: Guidelines and forms are available here. A copy of the application should be submitted to the RGP for review at least one week in advance of the submission deadline for follow-up purposes. Applications require the following endorsements:

  • From the Feinberg Graduate School: Confirmation that if and when the fellowship is approved, the candidate will be eligible to be a post-doc at the Weizmann Institute for the entire duration of the proposed fellowship.
  • From the candidate's supervisor (a Weizmann Institute researcher of rank Senior Scientist or higher): Confirmation that the supervisor agrees to host the post-doc for the entire period of the fellowship.

Please note that according to Weizmann Institute procedures, fellowships are paid as stipends at a fixed rate. Consequently, if the amount provided by the funding source is lower than this rate, the difference will have to be supplemented (with an a priori written commitment to this effect to the RGP) by the host researcher at the Institute.

If the fellowship on offer is higher than the Weizmann Institute standard rate, the Institute will be able to receive a stipend only up to its standard rate. Alternatively, if allowable by the funding agency, the fellowship can be paid by the agency directly to the bank account of the recipient. In such a case, the host researcher should apply for post-doctoral status for the fellow at the Institute, either with or without the additional standard Weizmann Institute post-doctoral stipend (as allowable by the external funding source, and according to the resources available to the prospective Weizmann Institute host). For further information and/or clarifications, please contact the Feinberg Graduate School or the RGP.

Please note that foreigners are required to obtain the relevant visa (i.e. for a fixed-amount stipend: category A2; or for an employment contract: category B1 = work permit) prior to taking up an appointment at the Weizmann Institute:

  • Non-Israeli fellows receiving a post-doctoral fixed-amount stipend at the Weizmann Institute standard rate are required to obtain a category A2 [student] visa, with the assistance of the Feinberg Graduate School.
  • In the case of an external funding source which is willing to provide support only in the form of a salary with social benefits (as opposed to a stipend), the fellow must be engaged by the Institute as a Visiting Scientist on an individual contract. In order to obtain approval for Visiting Scientist status, the prospective host must contact the Visiting Scientists Section at the Housing Directorate and follow their guidelines in this regard. The Visiting Scientsts Section will also assist in the procedures required for obtaining a B1 work permit visa. Please note that the procedures will be different, depending on the location of origin of the prospective Visiting Scientist:
    1. Foreigners intending to come to the Weizmann Institute from abroad, without having previously completed studies in Israel: the Visiting Scientists Section at the Housing Directorate must be contacted to initiate the B1 work permit visa application procedure, long enough in advance for the prospective Visiting Scientist to receive the visa at an Israeli embassy/consulate (outside of Israel), prior to his/her arrival in Israel.
    2. Foreigners who are currently in Israel and hold a category A2 [student] visa: According to the laws of the State of Israel as regards foreign citizens (who do not possess Israeli citizenship), engagement by the Institute of such researchers will only be possible if they a priori leave Israel and then return to an appointment as a Visiting Scientist (conditional upon approval of the Ministry of the Interior, which must agree to issue a category B1 work permit visa for this purpose).
    It should be noted that the work permit approval process - a prerequisite to the approval of the status of Visiting Scientist - usually takes several months. Consequently, a Weizmann Institute researcher intending to host a Visiting Scientist who is not an Israeli citizen should begin the relevant procedures several months in advance of the desired start date. For further details regarding the issue of obtaining a work permit for a Visiting Scientist, contact the Visiting Scientists Section at the Housing Directorate.

KEYWORDS: Life-Sciences
LAST UPDATED: 30 November 2011